HIGHLIGHTS
- who: M. Majem from the Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain have published the paper: SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018), in the Journal: (JOURNAL)
SUMMARY
Genetic profiling of NSCLC advanced disease is recommended in daily clinical practice by both ESMO and ASCO guidelines, as it has demonstrated to have an impact on patients' outcomes (I,A). In EGFR mutant patients progressing on first- or secondgeneration EGFR TKI, the detection of EGFR T790M secondary resistance mutations in tumor tissue is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.